Lapatinib Completed Phase 2 Trials for Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity / Stage IV Squamous Cell Carcinoma of the Hypopharynx / Salivary Gland Squamous Cell Carcinoma / Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity / Recurrent Squamous Cell Carcinoma of the Larynx / Stage IV Squamous Cell Carcinoma of the Nasopharynx / Stage IVB Salivary Gland Cancer / Stage IVC Squamous Cell Carcinoma of the Larynx / Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity / Stage IVA Verrucous Carcinoma of the Larynx / Tongue Cancer / Stage IVA Squamous Cell Carcinoma of the Larynx / Stage IVB Verrucous Carcinoma of the Oral Cavity / Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity / Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity / Stage IVB Squamous Cell Carcinoma of the Larynx / Stage IVA Salivary Gland Cancer / Recurrent Salivary Gland Cancer / Stage IVC Verrucous Carcinoma of the Oral Cavity / Stage IVB Verrucous Carcinoma of the Larynx / Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity / Stage IVC Squamous Cell Carcinoma of the Oropharynx / Recurrent Verrucous Carcinoma of the Larynx / Recurrent Squamous Cell Carcinoma of the Nasopharynx / Recurrent Squamous Cell Carcinoma of the Hypopharynx / Stage IVC Verrucous Carcinoma of the Larynx / Stage IVA Squamous Cell Carcinoma of the Oropharynx / Recurrent Verrucous Carcinoma of the Oral Cavity / Recurrent Squamous Cell Carcinoma of the Oropharynx / Stage IVA Verrucous Carcinoma of the Oral Cavity / Stage IVC Salivary Gland Cancer / Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity / Stage IVB Squamous Cell Carcinoma of the Oropharynx / Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00114283Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer